Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

272021-04

2020 Annual Report
072021-04

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2021
262021-03

(1) PROPOSED ELECTION OF DIRECTORS OF THE THIRD SESSION OF THE BOARD; AND (2) PROPOSED ELECTION OF SHAREHOLDER REPRESENTATIVE SUPERVISOR AND INDEPENDENT SUPERVISOR OF THE THIRD SESSION OF THE SUPERVISORY COMMITTEE
262021-03

ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020
122021-03

NOTICE OF BOARD MEETING
122021-03

CHANGE OF BUILDING NAME OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
022021-03

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021
012021-02

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2021
042021-01

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020
022020-12

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020
032020-11

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020
062020-10

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020

14 15 16 17 18

The Enterprise OA